Peter Van den Steen

5PUBLICATIONS
39CO-AUTHORS
Immunogenetics (incl. genetic immunology)Occupational epidemiologyDisease surveillanceInfant and child healthEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 30, 2024
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule.

Federico Martinón-Torres, Ignacio Salamanca de la Cueva, Michael Horn

|Feb 06, 2023
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.

Peter Van den Steen, Brigitte Cheuvart, Quentin Deraedt

|May 06, 2021
Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS Cohort.

Tom M A Wilkinson, Peter Van den Steen, Brigitte Cheuvart

|Aug 27, 2020
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.

Asmik Asatryan, Nadia Meyer, Michael Scherbakov

|Jun 20, 2019
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials.

Lidia Oostvogels, Thomas C Heineman, Robert W Johnson

Pageof 1

Frequent Collaborators

3 joint publications

Brigitte Cheuvart

2 joint publications

Nadia Meyer

1 joint publications

Lidia Oostvogels

1 joint publications

Thomas C Heineman